ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.

    O. Aubert,1 C. Lefaucheur,1 S. Higgins,1 L. Hidalgo,2 J. Duong Van Huyen,1 D. Viglietti,1 X. Jouven,1 D. Glotz,1 P. Halloran,2 A. Loupy.1

    1Paris Translational Research Center for Organ Transplantation, Paris, France; 2ATAGC, Edmonton, Canada

    BackgroundAntibody-mediated rejection (ABMR) can occur in patients with pre-existing anti-HLA donor-specific antibodies (DSA) or in patients who develop de novo DSA. However, how these processes…
  • 2017 American Transplant Congress

    Prospective Randomized Trial for Predicting CMV Infection According to Baseline CMV-Specific T-Cell Immunity in Kidney Transplant Patients.

    M. Jarque,2 E. Melilli,1 A. Gutierez,3 F. Moreso,4 L. Guirado,5 A. Manonelles,1 J. Cruzado,1,2 S. Luque,2 E. Crespo,2 N. Montero,1 F. Diekman,6 J. Grinyó,1,2 O. Bestard.1

    1Nephrology Dep, Bellvitge Hospital, Barcelona, Spain; 2Nephrology Laboratory, IDIBELL, Barcelona, Spain; 3Kidney Transplant Unit, Hospital Miguel Servet, Zaragoza, Spain; 4Kidney Transplant Unit, Hospital Vall d'Hebrón, Barcelona, Spain; 5Kidney Transplant Unit, Fundació Puigvert, Barcelona, Spain; 6Kidney Transplant Unit, Hospital Clínic, Barcelona, Spain

    Background: Despite the use of either anti-viral prophylaxis (PF) or preemptive (PE) therapy given based on donor/recipient IgG-serostatus, Cytomegalovirus (CMV) reactivation persists after kidney transplantation…
  • 2017 American Transplant Congress

    A Novel 3-Dimensional Culture System Enables In Vitro Study of Human Bone Marrow Plasma Cells.

    J. Driscoll,1 S. Tremblay,2 S. Knechtle,3 E. Woodle.2

    1Medicine, Univ Cincinnati, Cincinnati, OH; 2Surgery, Univ Cincinnati, Cincinnati, OH; 3Transplant, Duke Univ, Durham, NC

    Purpose: Historically, in vitro study of human plasma cells (PCs) has been greatly limited by their short survival (48-72 hrs). Therefore, systems that maintain viability…
  • 2017 American Transplant Congress

    Current Practice and Ethical Dimensions of Implementing APOL1 Testing into Living Donor Evaluation: A National Survey.

    E. Gordon,1 C. Wicklund,1 R. Sharp,2 J. Lee,1 C. Johnson,1 J. Friedewald.1

    1Northwestern University, Chicago; 2Mayo Clinic, Rochester

    BackgroundAfrican American (AA) live kidney donors (LKDs) have an even greater risk of kidney failure than European American live donors. Apolipoprotein 1 (APOL1) gene variants…
  • 2017 American Transplant Congress

    Disease Progression on Neoadjuvant Chemotherapy Is a Strong Predictor of Recurrence for Pediatric Hepatoblastoma.

    M. Kueht,1 S. Commander,1 T.-A. Ha,1 A. Rana,1,2 Y. Shi,1 S. Vasudevan,1,2 J. Goss.1,2

    1Surgery, Baylor College of Medicine, Houston; 2Surgery, Texas Children's Hospital, Houston

    Purpose. In addition to peri-operative chemotherapy, proper triage between orthotopic liver transplantation (OLT) and partial hepatectomy (PH) is critical to limiting disease recurrence in pediatric…
  • 2017 American Transplant Congress

    Antidepressant Medication Use Before and After Kidney Transplant: Implications for Post-Transplant Outcomes.

    K. Lentine,1 A. Naik,2 R. Ouseph,1 Z. Zhang,1 D. Axelrod,3 D. Segev,4 V. Dharnidharka,5 D. Brennan,5 H. Randall,1 R. Gadi,1 N. Lam,6 G. Hess,7 M. Schnitzler,1,8 B. Kasiske.8

    1St. Louis Univ, St. Louis; 2U of Michigan, Ann Arbor; 3East Carolina Univ, Greenville; 4Johns Hopkins, Baltimore; 5Washington Univ, St. Louis; 6Univ Alberta, Edmonton, Canada; 7Symphony Health, Philadelphia; 8Scientific Registry of Transplant Recipients, Minneapolis

    Limited data are available on the implications of antidepressant medication use in kidney transplant recipients.We examined a novel database wherein national transplant registry identifiers for…
  • 2017 American Transplant Congress

    In Vivo Administration of Plerixafor in Humans Mobilizes Bone Marrow Resident Plasma Cells That Demonstrate Apoptosis in Both Bone Marrow and Peripheral Blood.

    E. Woodle, S. Tremblay,1 C. Castro-Rojas,2 J. Driscoll,1 S. Knechtle,3 A. Shields,1 R. Alloway,1 D. Hildeman.2

    1University of Cincinnati, Cincinnati; 2Cincinnati Children's, Cincinnati; 3Duke, Durham

    Plasma-cell (PC) targeted therapies can reduce HLA sensitization. However, bone marrow (BM) niche resident plasma cells (BMNRPC) demonstrate resistance to proteasome inhibitor (PI) therapy. Plerixafor…
  • 2017 American Transplant Congress

    Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

    C. Jacquelinet,1 B. Audry,1 C. Antoine,1 C. Suberbielle,2 D. Glotz,2 A. Tambur.3

    1Agence de la Biomedecine, Saint Denis, France; 2Saint Louis Hospital, Paris, France; 3Northwestern University, Chicago

    To increase the likelihood of finding a compatible donor, kidney allocation systems prioritize highly sensitized patients to counterbalance the impact of HLA allo-sensitization and preclude…
  • 2017 American Transplant Congress

    Preliminary Results of Clinical Normothermic Ex Vivo Liver Perfusion in a North American Setting.

    M. Bral,1 B. Gala-Lopez,1 D. Bigam,1 N. Kneteman,1 A. Malcolm,1 S. Livingstone,1 A. Andres,1 J. Emamaullee,1 L. West,1 P. Friend,2 A. Shapiro.1

    1Department of Surgery, University of Alberta, Edmonton, AB, Canada; 2Department of Surgery, Nuffield Department of Surgical Sciences, Oxford, United Kingdom; 3Oxford Institute of Biomedical Engineering, Oxford, United Kingdom; 4OrganOx, Oxford, United Kingdom

    Outcomes of a first clinical normothermic machine perfusion (NMP) UK liver trial demonstrated feasibility and clear safety, with improved liver function when compared to standard…
  • 2017 American Transplant Congress

    Truth in Pathology: Autopsy Findings in Lungs Declined for Transplantation.

    A. Friedman, J. Lewis, H. Irving, K. Delli Carpini.

    LiveOnNY, New York, NY

    Healthy lungs are scarce among available organ donors who are becoming progressively older and have increasing numbers of comorbidities. Selection criteria that include excellent oxygenation…
  • « Previous Page
  • 1
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences